Human DMBT1-Derived Cell-Penetrating Peptides for Intracellular siRNA Delivery
Small interfering RNA (siRNA) is a promising molecule for gene therapy, but its therapeutic administration remains problematic. Among the recently proposed vectors, cell-penetrating peptides show great promise in in vivo trials for siRNA delivery. Human protein DMBT1 (deleted in malignant brain tumo...
Saved in:
Main Authors: | Martina Tuttolomondo (Author), Cinzia Casella (Author), Pernille Lund Hansen (Author), Ester Polo (Author), Luciana M. Herda (Author), Kenneth A. Dawson (Author), Henrik J. Ditzel (Author), Jan Mollenhauer (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Versatility of cell-penetrating peptides for intracellular delivery of siRNA
by: Tejinder Singh, et al.
Published: (2018) -
High DMBT1 concentrations in breast milk correlate with increased risk of infection in preterm and term neonates
by: Ronellenfitsch Sebastian, et al.
Published: (2012) -
Development of siRNA lipoplexes for intracellular delivery in lung cancer cells
by: N Khatri, et al.
Published: (2012) -
Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles
by: Borja Ballarín-González, et al.
Published: (2013) -
Cell-Penetrating Peptide and siRNA-Mediated Therapeutic Effects on Endometriosis and Cancer In Vitro Models
by: Kristina Kiisholts, et al.
Published: (2021)